A Cures Act–Forged Pathway to Patient-Tailored Radiopharmaceutical Therapy and Call for Regulatory Transparency
Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing precision medicine. As the field grows, a long-standing question gains renewed relevance: What role will personalized dosimetry play in shaping its future? Dosimetry-guided
Authors
- Adam Kesner
- Pat Zanzonico (ORCID: https://orcid.org/0000-0002-7334-2752)
- Cathy S. Cutler
- Nikki Batista
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Brookhaven National Laboratory (US)
- Oldham Council (GB)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2025-11-20
- DOI
- https://doi.org/10.2967/jnumed.125.270348
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00